Evidence map›Paper›PMID 19028103›Full record

ArticleBioorganic & medicinal chemistry2009

From nature to the laboratory and into the clinic.

K C Nicolaou, Jason S Chen, Stephen M Dalby

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. TheMolecules (Basel, Switzerland) · 2023
    Article
  4. Naturally Occurring Organohalogen Compounds-A Comprehensive Review.Progress in the chemistry of organic natural products · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Total synthesis of jiadifenolide.Angewandte Chemie (International ed. in English) · 2014
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Design, synthesis, and biological evaluation of a biyouyanagin compound library.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  17. Total synthesis and configurational assignment of chondramide A.Chemistry (Weinheim an der Bergstrasse, Germany) · 2010
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

K C NicolaouDepartment of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, BCC408, La Jolla, CA 92037, USA. kcn@scripps.edu
Jason S Chen
Stephen M Dalby

Funding

TOTAL SYNTHESIS OF THIOSTREPTONR01AI055475 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NICOLAOU, K. C. · 2002 to 2014
$7.0M
TOTAL SYNTHESIS OF AZASPIRACIDSR01ES013314 · NIEHS · SCRIPPS RESEARCH INSTITUTE, THE · PI NICOLAOU, K. C. · 2005 to 2011
$3.1M
TOTAL SYNTHESIS OF KINAMYCINS AND LOMAIVITICINSR01CA100101 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI NICOLAOU, K. C. · 2006 to 2010
$2.5M
NCI NIH HHS R01 CA100101NIAID NIH HHS R01 AI055475NIEHS NIH HHS R01 ES013314
6 · The paper itself

Abstract

Natural products possess a broad diversity of structure and function, and they provide inspiration for chemistry, biology, and medicine. In this review article, we highlight and place in context our laboratory's total syntheses of, and related studies on, complex secondary metabolites that were clinically important drugs, or have since been developed into useful medicines, namely amphotericin B (1), calicheamicin gamma(1)(I) (2), rapamycin (3), Taxol (4), the epothilones [e.g., epothilones A (5) and B (6)], and vancomycin (7). We also briefly highlight our research with other selected inspirational natural products possessing interesting biological activities [i.e., dynemicin A (8), uncialamycin (9), eleutherobin (10), sarcodictyin A (11), azaspiracid-1 (12), thiostrepton (13), abyssomicin C (14), platensimycin (15), platencin (16), and palmerolide A (17)].

Indexed as

Biological ProductsAnimalsDrug Evaluation, PreclinicalHumansLaboratoriesBiological Products

Identifiers

PMID19028103
PMCPMC2665039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.